Filters
Use basic filters below or open advanced options for more precise results.
Last dataset refresh: 17 Jun 2026
| Product name | Classification | Strength | Form | Manufacturer | Country of origin | Status | Registered On | Action | |
|---|---|---|---|---|---|---|---|---|---|
|
xigduo™ XR 10 mg/1000 mg
|
Conventional Medicines | 10 mg/1000 mg | Tablet | ASTRAZENECA PHARMACEUTICALS LP, United States of America, Mount Vernon | Sweden | Active | 10 Jun 2015 | View details → | |
|
xigduo™ XR 10 mg/500 mg
|
Conventional Medicines | 10 mg/500 mg | Tablet | ASTRAZENECA PHARMACEUTICALS LP, United States of America, Mount Vernon | Sweden | Active | 10 Jun 2015 | View details → | |
|
xigduo™ XR 5 mg/1000 mg
|
Conventional Medicines | 5 mg/1000 mg | Tablet | ASTRAZENECA PHARMACEUTICALS LP, United States of America, Mount Vernon | Sweden | Active | 10 Jun 2015 | View details → | |
|
xigduo™ XR 5 mg/500 mg
|
Conventional Medicines | 5 mg/500 mg | Tablet | ASTRAZENECA PHARMACEUTICALS LP, United States of America, Mount Vernon | Sweden | Active | 10 Jun 2015 | View details → | |
|
xiidra® 5%
|
Conventional Medicines | 5% (50 mg/ml) | Solution | The Ritedose Corporation , United States of America, Columbia | United States of America | Active | 11 Jun 2018 | View details → | |
|
Ximluci™ 10 mg/mL
|
Biological Medicines | 10 mg/ml | Injection | STADA ARZNEIMITTEL AG, Germany, Bad Vilbel | Germany | Active | 13 Dec 2023 | View details → | |
|
XINCLAV 1.2
|
Conventional Medicines | Combination | Injection | AUROBINDO PHARMA LIMITED, UNIT XII , India, Telangana | India | Active | 18 Mar 2015 | View details → | |
|
Xlography ® 300 mg I/ml
|
Conventional Medicines | 300 mg I/ml | Injection | Tabuk Pharmaceutical Manufacturing Co, Saudi Arabia, Dammam | Saudi Arabia | Active | 27 Mar 2023 | View details → | |
|
Xofluza® 40 mg
|
Conventional Medicines | 40 mg/Tablet | Tablet | F.Hoffmann - La Roche Ltd Basel Contract Organizations, Switzerland, 4058 Basel | Switzerland | Active | 17 Mar 2019 | View details → | |
|
Xofluza® 40 mg
|
Conventional Medicines | 40 mg/Tablet | Tablet | F.Hoffmann - La Roche Ltd Basel Contract Organizations, Switzerland, 4058 Basel | Switzerland | Active | 17 Mar 2019 | View details → | |
|
Xolair® 150 mg
|
Biological Medicines | 150 mg/mL | Injection | VETTER PHARMA-FERTGUNG GMBH & CO. KG, Germany, 88212 Ravensburg | Ireland | Active | 13 Apr 2020 | View details → | |
|
Xolair® 150 mg (PFP)
|
Biological Medicines | 150mg/1ml | Injection | NOVARTIS PHARMA STEIN AG, Switzerland, STEIN | Ireland | Active | 03 Dec 2025 | View details → | |
|
Xolair® 300 mg (PFP)
|
Biological Medicines | 300mg/2ml | Injection | NOVARTIS PHARMA STEIN AG, Switzerland, STEIN | Ireland | Active | 03 Dec 2025 | View details → | |
|
Xolair® 75 mg
|
Biological Medicines | 75 mg/0.5mL | Injection | VETTER PHARMA-FERTGUNG GMBH & CO. KG, Germany, 88212 Ravensburg | Ireland | Active | 13 Apr 2020 | View details → | |
|
Xolair® 75 mg (PFP)
|
Biological Medicines | 75mg/0.5ml | Injection | NOVARTIS PHARMA STEIN AG, Switzerland, STEIN | Ireland | Active | 03 Dec 2025 | View details → | |
|
Xolamol ™ 20mg/5mg
|
Conventional Medicines | Combination | Drops | JAMJOOM PHARMACEUTICALS FACTORY COMPANY , Saudi Arabia, Jeddah | Saudi Arabia | Active | 14 Oct 2008 | View details → | |
|
Xolamol™ U.D
|
Conventional Medicines | 20mg/ml + 5mg/ml | Eye Drops | JAMJOOM PHARMACEUTICALS FACTORY COMPANY , Saudi Arabia, Jeddah | Saudi Arabia | Active | 18 Jan 2024 | View details → | |
|
XOLSTAT® 10 mg
|
Conventional Medicines | 10 mg/tablet | Tablet | Sun Pharmaceutical Industries Limited, India, Himachal Pradesh | India | Active | 07 Feb 2018 | View details → | |
|
XOLSTAT®20 mg
|
Conventional Medicines | 20 mg/tablet | Tablet | Sun Pharmaceutical Industries Limited, India, Himachal Pradesh | India | Active | 07 Feb 2018 | View details → | |
|
Xonvea
|
Conventional Medicines | 10 mg/10 mg/Tablet | Tablet | DUCHESNAY INC., Canada, BLAINVILLE | Spain | Active | 22 Mar 2022 | View details → | |
|
Xonvea® 20 mg/20 mg
|
Conventional Medicines | 20 mg/20 mg/Tablet | Tablet | DUCHESNAY INC., Canada, BLAINVILLE | Spain | Active | 24 Mar 2025 | View details → | |
|
XOSPATA™ 40 mg
|
Conventional Medicines | 40 mg/Tablet | Tablet | Delpharm Meppel B. V., Netherlands, 7942 JG, Meppel | Netherlands | Active | 31 Aug 2020 | View details → | |
|
Xpel 15 mg / 5ml
|
Conventional Medicines | 15 mg / 5ml | Syrup, Sugar Free | Neopharma, United Arab Emirates, Abu Dhabi | United Arab Emirates | Active | 17 Jun 2010 | View details → | |
|
Xpel 30 mg / 5ml
|
Conventional Medicines | 30 mg / 5ml | Syrup, Sugar Free | Neopharma, United Arab Emirates, Abu Dhabi | United Arab Emirates | Active | 06 Dec 2012 | View details → |
Compare selected products
0 of 3 selected